What's Happening?
Abbott has partnered with Flatiron Health to integrate its Precision Oncology testing portfolio into Flatiron's OncoEMR, a cloud-based Electronic Medical Record platform. This integration allows oncology providers to order Abbott's specialized cancer
tests directly from the patient's chart, streamlining the process and reducing administrative burdens. The integration aims to enhance the efficiency of cancer care by embedding advanced genomic and oncological diagnostics into the daily workflow of community cancer care centers.
Why It's Important?
This integration is significant as it reduces the administrative workload for clinicians, allowing them to focus more on patient care. By embedding advanced diagnostics directly into the EMR system, the integration facilitates quicker and more efficient decision-making in cancer treatment. This is particularly important in community settings where the majority of cancer care occurs, making advanced diagnostics more accessible and potentially improving patient outcomes.
What's Next?
The integration is expected to improve the workflow for over 1,600 community cancer care centers and 4,700 providers within Flatiron's network. As the integration progresses, it may lead to further collaborations and innovations in precision medicine, potentially setting a new standard for how cancer diagnostics are integrated into clinical practice. The success of this integration could encourage other healthcare providers to adopt similar systems, further advancing the field of precision oncology.
